Left Atrial Appendage Closure Device with Snare Tensioning

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for addressing thrombus formation in the left atrial appendage, such as open-heart surgery, are invasive and carry significant risks, and alternative minimally invasive techniques are not effective in preventing blood flow into the appendage.

Innovation Solution

Development of closure devices featuring a snare loop assembly with a suture loop and tensioning devices that allow for controlled ligation of the left atrial appendage, using a snare loop assembly that can be mounted on a handle and includes force-reducing suture locks and tensioning mechanisms to ensure secure closure without disengagement.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If open-heart surgery is used to suture the left atrial appendage, then effective closure and thrombus prevention are achieved, but patient risk and invasiveness increase significantly

Engineering Contradiction:
Improveclosure effectivenessVSAvoidpatient risk
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces the mechanical open-heart surgical system with a minimally invasive intravascular delivery system. The closure device is delivered through a catheter via the vasculature, eliminating the need for chest opening, cardiopulmonary bypass, and general anesthesia, thus reducing patient risk while maintaining closure effectiveness

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces a minimally invasive closure device as an intermediary between the surgeon and the left atrial appendage. This device can be delivered through a catheter and deployed inside the appendage or at its base, providing effective closure without requiring direct surgical access to the heart

Inventive Principle:
Principle #24Intermediary (Mediator)

2Object-affected harmful factors

If minimally invasive intravascular approaches are used, then patient risk is reduced, but closure effectiveness and blood flow prevention may be compromised

Engineering Contradiction:
Improvepatient riskVSAvoidclosure effectiveness
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The closure device is segmented into multiple functional components: a delivery catheter for minimally invasive access, a closure element (such as a snare, loop, or occluder) for effective sealing, and a deployment mechanism for controlled release. This segmentation allows the device to navigate the vasculature easily while maintaining the capability for secure closure

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The device utilizes parameter changes such as shape memory effects or phase transitions to enable the closure element to transform from a compressed delivery state to an expanded functional state upon deployment, ensuring effective closure while maintaining minimally invasive delivery

Inventive Principle:
Principle #35Parameter changes

3Reliability

If the suture loop is tensioned to ensure secure closure, then closure reliability improves, but the risk of suture disengagement or tissue damage increases

Engineering Contradiction:
Improveclosure securityVSAvoidsuture integrity
Core Design Contradiction:
ReliabilityVSStrength

Solution Approach 1:

The tensioning device incorporates feedback mechanisms such as force sensors, displacement sensors, or torque sensors that provide real-time information about the tension applied to the suture loop. This feedback allows the operator to monitor and control the tension within safe limits, ensuring secure closure without exceeding the strength thresholds of the suture or tissue

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The tensioning device allows dynamic adjustment of suture tension during the procedure. The operator can gradually increase tension while monitoring tissue response and suture behavior, enabling optimization of closure security while preventing excessive force that could cause disengagement or damage

Inventive Principle:
Principle #15Dynamics

Data Source

PatentUS11026690B2Tissue ligation devices and tensioning devices therefor
Publication Date: 2021.06.08 SENTREHEART LLC
  • US11026690B2 patent drawing
  • US11026690B2 patent drawing
  • US11026690B2 patent drawing

AI summary

Described here are closure devices and methods for ligating tissue, such as the left atrial appendage, and tensioning devices and mechanism for actuating these devices. The tensioning mechanisms and devices may allow a user to apply one or more predetermined forces to a suture or other portion of the closure devices. The closure devices may comprise a suture loop releasably attached to a snare loop assembly, and a tensioning mechanism or device may be configured to tighten the suture loop and/or release the suture loop from the snare loop assembly.